Global Growth

STRATEGY/TACTICS/EXECUTION

For the Consumer Healthcare, Health & Beauty, and CPG worlds

Rowland Global, LLC.

Go Global, Grow Global to reach the next level
Full-scale strategy development for business and brand growth
Customized analysis and hands-on execution serving start-ups to mature businesses

About Us

Why Rowland Global:

On-the-ground experience in every major region of the world
Fortune 50 training AND small company agility
Multi-cultural, multi-lingual insight

Unique cross-discipline range: Strategy, Logistics/Operations, Finance and Marketing & Sales
Common sense & creativity combined with quantitative rigor
Customized tailored deep analysis

Ed Rowland is a Contributing Editor to Chain Drug Review, a Special Commentator for Nicholas Hall OTC Insight North America, an expert author for the Natural Products Field Manual and a frequent industry conference and University guest lecture speaker. On January 1, 2019 he became the Co-Chair of the Executive Forum.

View All Insights

COVID-19 Featured Insight Series

We are all now living with the challenging realities of the Coronavirus. As part of a special series for Chain Drug Review as a Global Contributing Editor I have teamed up with a Chinese colleague Alice Wang to describe the impact on China. They are several months ahead of us in responding. This collaboration was born from meetings from previous Chinese e-commerce business negotiations. Alice has recently left Alibaba’s Healthcare Division and has deep consumer healthcare roots. We both hope that our ongoing articles bring to life the challenges of coping and provide useful information as to what is coming.

Part 1: A Chinese Worker Dreams of Returning to the Office

Part 2: Virus Shakes up China’s Manufacturing Sector

Part 3: The Coronavirus and Education in China

Part 4: QR Code a Key Part of China’s COVID-19 Response

Part 5: Coronavirus Rumors Shape Consumer Behavior

Part 6: Returning to Work and Facing a New Normal

Part 7: China Taps Digital Coupons in Rebound Effort

Part 8: In China, Health and Illness Both Come by Mouth

Part 9: A Dog’s Life in China is Improving

Featured Insight

Delighted to once again provide Nicholas Hall’s CHC Insight North America a look back at a most challenging year, 2020, below. Thank you to Chain Drug Review’s sister publication MMR for republishing an abridged version of the article. It’s a pleasure to contribute to all three leading industry publications.

The 2020 Year in Review, Nicholas Hall’s OTC Insights North America (January 2021)

Press Release: New partnership with OOVA Inc. (Business Strategy Advisor)

Recent Insight

OOVA Launch Press Release (September 2020)

Pandemic Could Bring a Reckoning for ‘Canadian Pharmacy’ (July 2020)

Chinese COVID-19 Experience Presentation at the Executive Forum’s Town Hall (May 2020)

Proud and excited to be an OOVA Advisor. Product launch April 20, 2020!

Lecture at Rutgers Business School at the School of Communication and Information Supply Chain and Information Technology (February 2020)

Upcoming Insight

Be on the lookout for more global commentary in Chain Drug Review!

I would like to publicly express my sincere thanks to Drug Store News for the opportunity to serve as a Contributing Editor for the last several years. During almost 4 years of association, it was a pleasure to provide 15+ different articles covering a variety of global issues impacting the consumer healthcare world. It was a proud moment when one of those contributions was the most read DSN article in 2017. Also, a big thank you is due to the helpful and supportive DSN editorial staff. Their suggestions and comments improved many of the articles. It was a positive constructive collaboration and I will miss working with them.

In 2019, I am moving over to Chain Drug Review in the same capacity. I look forward to working with the CDR team and will continue to provide informative and entertaining content covering global issues important to the consumer healthcare world.